Lyfegen Introduces AI Solution for Drug Contracting

Lyfegen, a pioneer in drug access solutions, has launched its AI Contracting Companion, an innovative tool aimed at streamlining drug pricing and contracting processes. This new AI capability addresses the increasing complexity in global drug pricing strategies and aims to accelerate patient access to therapies.

Amid evolving international pricing policies, Lyfegen's solution creates a unified decision-making platform. It integrates clinical evidence, pricing constraints, and payer behavior to produce structured contracting strategies and rebate scenarios, fostering efficient local decision-making within global frameworks.

The AI Contracting Companion is built on the principles of Integration, Profundity, and Accountability. It enhances expert judgment by providing transparent, repeatable outputs while ensuring confidentiality. The platform was showcased at the World Evidence, Pricing and Access Congress in Amsterdam.